Greenland Mines Ltd. Common Stock (NASDAQ:GRML) Director Riad Hussein El-Dada Sells 3,500 Shares of Company Stock

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) Director Riad Hussein El-Dada sold 3,500 shares of Greenland Mines Ltd. Common Stock stock in a transaction dated Thursday, October 1st. The shares were sold at an average price of $9.35, for a total transaction of $32,725.00. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Greenland Mines Ltd. Common Stock Price Performance

Shares of GRML stock traded down $0.54 during trading hours on Monday, hitting $7.34. The company had a trading volume of 4,688,070 shares, compared to its average volume of 23,797,332. The stock has a market capitalization of $23.32 million, a PE ratio of -0.64 and a beta of 6.26. The company’s fifty day moving average is $8.00 and its 200 day moving average is $15.04. Greenland Mines Ltd. Common Stock has a fifty-two week low of $2.82 and a fifty-two week high of $36.99.

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) last posted its earnings results on Monday, August 17th. The company reported ($0.03) earnings per share for the quarter.

Analysts Set New Price Targets

GRML has been the topic of several research analyst reports. Weiss Ratings upgraded Greenland Mines Ltd. Common Stock from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, September 24th. Wall Street Zen upgraded Greenland Mines Ltd. Common Stock to a “sell” rating in a report on Saturday, August 29th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Greenland Mines Ltd. Common Stock currently has a consensus rating of “Sell”.

Hedge Funds Weigh In On Greenland Mines Ltd. Common Stock

An institutional investor recently bought a new position in Greenland Mines Ltd. Common Stock stock. State Street Corp bought a new stake in Greenland Mines Ltd. Common Stock (NASDAQ:GRML) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 302,500 shares of the company’s stock, valued at approximately $79,000. State Street Corp owned about 9.51% of Greenland Mines Ltd. Common Stock at the end of the most recent reporting period. 20.07% of the stock is currently owned by hedge funds and other institutional investors.

Greenland Mines Ltd. Common Stock Company Profile

Klotho Neurosciences, Inc, a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan’s Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases.